Approaches to the prevention and management of radiation colitis

Current Gastroenterology Reports

Volumn 10, Issue 5, 2008, Pages 507-513

  Qadeer, Mohammed A ^a   Vargo, John J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; AMINOSALICYLIC ACID; BETAMETHASONE; CORTICOSTEROID; ESTROGEN; FORMALDEHYDE; GLUTAMINE; MESALAZINE; METRONIDAZOLE; OXYGEN; PLACEBO; PREDNISOLONE; SALAZOSULFAPYRIDINE; SUCRALFATE;

ANASTOMOSIS LEAKAGE; ANTINEOPLASTIC ACTIVITY; ARGON PLASMA COAGULATION; BALLOON DILATATION; BLEEDING DISORDER; BRACHYTHERAPY; BUERGER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COLON FISTULA; COLON ISCHEMIA; COLON ULCER; DEFECATION DISORDER; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG MEGADOSE; ENDOSCOPIC SURGERY; FECES INCONTINENCE; GASTROINTESTINAL SYMPTOM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE FISTULA; INTESTINE NECROSIS; PAIN; PALLOR; PATIENT CARE PLANNING; PELVIC DISEASE; PROCTOCOLITIS; RADIATION INJURY; RADIATION PROTECTION; RECTUM DISEASE; RECTUM HEMORRHAGE; REVIEW; RISK REDUCTION; SKIN IRRITATION; SYMPTOMATOLOGY; TELANGIECTASIA; TENESMUS; UNSPECIFIED SIDE EFFECT; ARTICLE; COLITIS;

COLITIS; HUMANS; RADIATION INJURIES;

EID: 58149337270     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0093-9     Document Type: Review

References (51)

1. Babb RR: Radiation proctitis: A review. Am J Gastroenterol 1996, 91: 1309-1311.
2. Cho LC, Antoine JE: Radiation injury to the gastrointestinal tract. In Sleisenger and Fordtran's Gastrointestinal and Liver Disease, edn 8. Edited by Feldman M, Friedman LS, and Brandt LJ. Philadelphia: Saunders Elsevier; 2006;813-826.
3. Gilinsky NH, Burns DG, Barbezat GO, et al.: The natural history of radiation-induced proctosigmoiditis: An analysis of 88 patients. Q J Med 1983, 52: 40-53.
4. Schultheiss TE, Lee WR, Hunt MA, et al.: Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37: 3-11.
5. Schultheiss TE, Lee WR, Hunt MA, Lee R: Incidence of and factors related to late complications in coformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1995, 32: 643-649.
6. Beard CJ, Propert KJ, Rieker PP, et al.: Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997, 15: 223-229.
7. Teshima T, Hanks GE, Hanlon AL, et al.: Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 1997, 39: 77-83.
8. Snyder KM, Stock RG, Hong SM, et al.: Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2001, 50: 335-341.
9. Anseline PF, Lavery IC, Fazio VW, et al.: Radiation injury of the rectum: Evaluation of surgical treatment. Ann Surg 1981, 194: 716-724
10. Lucarotti ME, Mountford RA, Bartolo DC: Surgical management of radiation injury. Dis Colon Rectum 1991, 34: 865-869.
11. O'Brien PC, Hamilton CS, Denham, JW, Gourlay R: Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58: 75-80.
12. Bernhard EJ, McKenna WG, Muschel RJ: Radiosensitivity and the cell cycle. Cancer J Sci Am 1999, 5: 194-204.
13. Jones BA, Gores GJ: Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol 1997, 273: G1174-G1188.
14. Metcalfe A, Streuli C: Epithelial apoptosis. Bioassays 1997, 19: 711-720.
15. Potten CS, Booth C: The role of radiation induced and spontaneous apoptosis in the homeostasis of gastrointestinal epithelium. Comp Biochem Physiol 1997, 3: 473-478.
16. Wang J, Zheng H, Sung CC, et al.: Cellular sources of transforming growth factor bisoforms in early and chronic radiation enteropathy. Am J Pathol 1998, 5: 1531-1540.
17. Langberg CW, Hauer-Jensen M, Sung CC, Kane CJ: Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 1994, 32: 29-36.
18. Richter KK, Langberg CW, Sung CC, Hauer-Jensen M: Increased transforming growth factor β (TGF-β) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Int J Radiat Oncol Biol Phys 1997, 39: 187-195.
19. Skwarchuk MW, Travis EL: Changes in histology and fibrogenic cytokines in irradiated colorectum of two murine strains. Int J Radiat Oncol Biol Phys 1998, 42: 169-178.
20. Isaka Y, Brees DK, Ikegaya K, et al.: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996, 2: 418-423.
21. Herskind C, Bamberg M, Rodemann HP: The role of cytokines in the development of normal tissue reactions after radiotherapy. Strahlenther Onkol 1998, 174(Suppl 3): 12-15.
22. Cohen L, Creditor M: Iso-effect tables for tolerance of irradiated normal human tissue. Int J Radiat Oncol Biol Phys 1983, 2: 233-241.
23. Melian E, Mageras GS, Fuks Z, et al.: Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 1997, 38: 73-81.
24. Ling CC, Burman C, Chui CS, et al.: Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996, 35: 721-730.
25. Fraass BA, Kessler ML, McShan DL, et al.: Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy. Semin Radiat Oncol 1999, 9: 60-77.
26. Hanks GE, Hanlon AL, Schultheiss TE, et al.: Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998, 41: 501-510.
27. Rossi CJ Jr, Slater JD, Reyes-Molyneux N, et al.: Particle beam radiation therapy in prostate cancer: Is there an advantage? Semin Radiat Oncol 1998, 8: 115-123.
28. Zietman AL, DeSilvio ML, Slater JD, et al.: Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005, 294: 1233-1239.
29. Keefe DM, Schubert MM, Elting LS, et al.: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007, 109: 820-831.
30. Schuchter LM, Glick J: The current staAus of WR-2721 (amifostine): a chemotherapy and radiation therapy protector. Biologic Ther Cancer 1993, 2: 1-10.
31. Liu T, Liu Y, He S, et al.: Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer 1992, 69: 2820-2825.
32. Athanassiou H, Antonadou D, Coliarakis N, et al.: Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial. Int J Radiat Oncol Biol Phys 2003, 56: 1154-1160.
33. Kouloulias VE, Kouvaris JR, Pissakas G, et al.: Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: Topical intrarectal versus subcutaneous application. Int J Radiat Oncol Biol Phys 2005, 62: 486-493.
34. Taylor JG, DiSario JA, Buchi KN: Argon laser therapy for hemorrhagic radiation proctitis. Long-term results. Gastrointest Endosc 1993, 39: 641-644.
35. Silva RA, Correia AJ, Dias LM, et al.: Argon plasma coagulation therapy for hemorrhagic radiation proctosigmoiditis. Gastrointest Endosc 1999, 50: 221-224.
36. Fantin AC, Binek J, Suter WR, Meyenberger C: Argon beam coagulation for treatment of symptomatic radiation-induced proctitis. Gastrointest Endosc 1999, 49: 515-518.
37. Taieb, S, Rolachon, A, Cenni, JC, et al.: Effective use of argon plasma coagulation in the treatment of severe radiation proctitis. Dis Colon Rectum 2001, 44: 1766-1771.
38. Tjandra JJ, Sengupta S: Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis. Dis Colon Rectum 2001, 44: 1759-1765.
39. Ben Soussan E, Mathieu N, Roque I, Antonietti M: Bowel explosion with colonic perforation during argon plasma coagulation for hemorrhagic radiation-induced proctitis. Gastrointest Endosc 2003, 57: 412-413.
40. Jensen DM, Machicado GA, Cheng S, et al.: A randomized prospective study of endoscopic bipolar electrocoagulation and heater probe treatment of chronic rectal bleeding from radiation telangiectasia. Gastrointest Endosc 1997, 45: 20-25.
41. Mathai V, Seow-Choen F: Endoluminal formalin therapy for haemorrhagic radiation proctitis. Br J Surg 1995, 82: 190.
42. de Parades V, Etienney I, Bauer P, et al.: Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis - an effective but not risk-free procedure: A prospective study of 33 patients. Dis Colon Rectum 2005, 48: 1535-1541.
43. Haas EM, Bailey HR, Farragher I: Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis. Dis Colon Rectum 2007, 50: 213-217.
44. Cullen SN, Frenz M, Mee A: Treatment of haemorrhagic radiation-induced proctopathy using small volume topical formalin instillation. Aliment Pharmacol Ther 2006, 23: 1575-1579.
45. Kochhar R, Patel F, Dhar A, et al.: Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci 1991, 36: 103-107.
46. Kochhar R, Sriram PV, Sharma SC: Natural history of the radiation proctosigmoiditis treated with topical sucralfate. Dig Dis Sci 1999, 44: 973-978.
47. Leach RM, Rees PJ, Wilmhurst P: Hyperbaric oxygen therapy. BMJ 1998, 317: 1140-1143.
48. Baum CA, Biddle WL, Miner PB Jr: Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis. Dig Dis Sci 1989, 34: 758-760.
49. Talley NA, Chen F, King D, et al.: Short-chain fatty acids in the treatment of radiation proctitis: A randomized, double-blind, placebo-controlled, cross-over pilot trial. Dis Colon Rectum 1997, 40: 1046-1050.
50. Cavcic J, Turcic J, Martinac P, et al.: Metronidazole in the treatment of chronic radiation proctitis: Clinical trial. Croat Med J 2000, 41: 314-318.
51. Wurzer H, Schafhalter-Zoppoth I, Brandstatter G: Hormonal therapy in chronic radiation colitis. Am J Gastroenterol 1998, 93: 2536-2538.